Recipharm Bolsters pharma development capabilities with strategic funding

Recipharm, a top global pharmaceutical CDMO, is enhancing its pharmaceutical development abilities by making strategic investments and incorporating advanced technologies. This investment enhances its offerings for both early and late-stage...

Liquidia and Pharmosa Biopharm Team up to develop inhaled treprostinil

Liquidia Corporation and Pharmosa Biopharm have updated their exclusive licensing agreement for L606, an inhaled, sustained-release treprostinil formulation. The drug is currently in a clinical trial for treating pulmonary arterial hypertension...

Emcure Pharma and Gilead Sciences Team up to produce HIV prevention drug

Emcure Pharmaceuticals announced a royalty-free voluntary licensing agreement with Gilead Sciences Ireland UC, a subsidiary of the California-based Gilead Sciences, to manufacture and supply generic versions of lenacapavir, the antiretroviral...

Sapience Therapeutics Initiates patient enrolment in phase 2 study

Sapience Therapeutics, Inc., a biotechnology company in the clinical stage, has reported the enrollment of the initial patient in its phase 2 dose expansion study for ST316, the company's innovative antagonist of b-catenin. The study's phase 1...

Merck Concludes Acquisition of investigational B-cell Depletion Therapy

Merck, also recognized as MSD in countries other than the United States and Canada, revealed the finalization of the acquisition of CN201 from Curon Biopharmaceutical (Curon), a new experimental bispecific antibody in clinical development for...

CCI Approves Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines deal

The Competition Commission of India (CCI) gave approval to Mankind Pharma's acquisition of Bharat Serums and Vaccines for Rs 13,630 crore. Mankind Pharma, a publicly traded company, is involved in creating, producing, and selling a wide variety of...

Sun Pharma and Philogen Ink Pact to commercialise speciality cancer drug

Sun Pharma announced that they have signed a worldwide licensing deal to market Philogen's specialty anti-cancer immunotherapy Fibromun (L19TNF) from Switzerland and Italy. bPhilogen is conducting registration trials for Fibromun to treat soft...

Genentech to Acquire CDK Inhibitors to treat breast cancer

Regor Pharmaceuticals (USA), a branch of Regor Therapeutics Group, a biotech company in the clinical testing phase, has agreed to a deal where Genentech, part of the Roche Group, will buy a set of advanced CDK inhibitors from Regor to treat breast...

Venus Remedies Receives Market Authorisations for two cancer drugs

Venus Remedies Ltd, a leading pharmaceutical company, announced that it has obtained approvals to market two important oncology medications (carboplatin and bortezomib) in Morocco and the Philippines. "These approvals are pivotal in our...

Boston Scientific Bags PDMA Nod in Japan for FARAPULSE PFA System

Boston Scientific Corporation, a leading company in the field of global medical technology, stated that it has been granted approval by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for the FARAPULSE Pulsed Field Ablation (PFA)...

© 2025 India Pharma Outlook. All Rights Reserved.